Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
BMC Pregnancy and Childbirth|March 29, 2025
Critical signs and symptoms for self-assessment in the immediate postnatal period: an international Systematic Scoping Review and Delphi consensus studyTeesta Dey, Nada Bassiony, Angela Hancock, et al.Journal of Pediatric Gastroenterology and Nutrition|May 23, 2020
Neurological Adverse Effects Associated With Anti-tumor Necrosis Factor Alpha Antibodies in Pediatric Inflammatory Bowel DiseasesValérie Bertrand, Nathalie Massy, Bénédicte Pigneur, et al.Nephron|July 15, 2021
AA Amyloidosis in the Course of HIV Infection: A Report of 19 Cases Including 4 New French Cases and a Comprehensive Review of LiteraturePaul Breillat, Valérie Pourcher, Samuel Deshayes, et al.The Journal of Rheumatology|March 17, 2020
Rituximab and Cyclophosphamide in Antisynthetase Syndrome-related Interstitial Lung Disease: An Observational Retrospective StudyVincent Langlois, André Gillibert, Yurdagül Uzunhan, et al.Journal of Autoimmunity|September 18, 2020
Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patientsQuentin Bodard, Vincent Langlois, Philippe Guilpain, et al.RMD Open|October 30, 2025
Joint involvement in VEXAS and non-VEXAS clonal haematopoiesis: two clusters from a multicentre regional cohortBaptiste de Maleprade, Fabien Jastrzebski, Ygal Benhamou, et al.Journal of Translational Autoimmunity|October 25, 2023
Are serum C3 levels or kidney C3 deposits useful markers for predicting outcomes in patients with ANCA-associated vasculitis?Alexis Cassard, Clément Kounde, Laurence Bouillet, et al.RMD Open|May 10, 2022
COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseasesRim Bourguiba, Maeva Kyheng, Isabelle Koné-Paut, et al.The Lancet. Rheumatology|March 31, 2021
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort studyJérôme Avouac, Elodie Drumez, Eric Hachulla, et al.Plos One|August 4, 2022
Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trialAlexandra Audemard-Verger, Amélie Le Gouge, Vincent Pestre, et al.Pageof 3